{
    "Trade/Device Name(s)": [
        "VARIANT II TURBO Hemoglobin A1c Program",
        "VARIANT II TURBO Hemoglobin Testing System With CDM 4.0"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K063400",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040872"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "LDM"
    ],
    "Summary Letter Date": "December 1, 2006",
    "Summary Letter Received Date": "November 9, 2006",
    "Submission Date": "November 8, 2006",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VARIANT II TURBO Hemoglobin Testing System"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-exchange high performance liquid chromatography (HPLC)",
        "Cation exchange high performance liquid chromatography"
    ],
    "Methodologies": [
        "Chromatographic separation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Software",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad VARIANT II TURBO Hemoglobin A1c Program utilizing HPLC and CDM 4.0 software for determination of HbA1c in whole blood",
    "Indications for Use Summary": "Intended for percent determination of hemoglobin A1c in human whole blood to monitor long-term glucose control in individuals with diabetes mellitus; for professional in vitro diagnostic use",
    "fda_folder": "Hematology"
}